top of page
  • General Inception

General Inception Launches Igniter Europe to leverage the unique European life sciences ecosystem and establish differentiated deeptech companies.

Lyon and San Francisco - April 30, 2024: General Inception announces the launch of Igniter Europe, focused on building innovative companies in the field of oncology, autoimmune and rare diseases, with novel therapeutics and disruptive technology platforms that enable accelerated drug development with data analytics solutions

leveraging patients’ data and clinical insights early on in the phase of drug development.

37 views0 comments


bottom of page